Literature DB >> 21432316

Metallothioneins and brain injury: What transgenic mice tell us.

Juan Hidalgo1.   

Abstract

In rodents, the metallothionein (MT) family is composed of four members, MT-1 to MT-4. MT-1&2 are expressed in virtually all tissues including those of the Central Nervous System (CNS), while MT-3 (also called Growth Inhibitory Factor) and MT-4 are expressed prominently in the brain and in keratinizing epithelia, respectively. For the understanding of the physiological functions of these proteins in the brain, the use of transgenic mice has provided essential information. Results obtained inMT-1&2-null mice and in MT-1-overexpressing mice strongly suggeset that these MT isoforms are important antioxidant, anti-inflammatory and antiapoptotic proteins in the brain. Results inMT-3-null mice show a very different pattern, with no support for MT-1&2-like functions. Rather, MT-3 could be involved in neuronal sprouting and survival. Results obtained in a model of peripheral nervous system injury also suggest that MT-3 could be involved in the control of nerve growth.

Entities:  

Keywords:  brain injury; cytokines; metallothionein; oxidative stress; transgenic mice

Year:  2004        PMID: 21432316      PMCID: PMC2723515          DOI: 10.1007/BF02898066

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  150 in total

1.  Changes in brain gene expression shared by scrapie and Alzheimer disease.

Authors:  J R Duguid; C W Bohmont; N G Liu; W W Tourtellotte
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 2.  Roles of the metallothionein family of proteins in the central nervous system.

Authors:  J Hidalgo; M Aschner; P Zatta; M Vasák
Journal:  Brain Res Bull       Date:  2001-05-15       Impact factor: 4.077

3.  Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion.

Authors:  M van Lookeren Campagne; H Thibodeaux; N van Bruggen; B Cairns; D G Lowe
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

4.  Differential expression of metallothioneins in human prion diseases.

Authors:  T Kawashima; K Doh-ura; M Torisu; Y Uchida; A Furuta; T Iwaki
Journal:  Dement Geriatr Cogn Disord       Date:  2000 Sep-Oct       Impact factor: 2.959

5.  Regulation of metallothionein gene expression by oxidative stress and metal ions.

Authors:  G K Andrews
Journal:  Biochem Pharmacol       Date:  2000-01-01       Impact factor: 5.858

6.  Sheep have an unusual variant of the brain-specific metallothionein, metallothionein-III.

Authors:  Roger S Chung; Adele F Holloway; Bedrich L Eckhardt; Julie A Harris; James C Vickers; Meng Inn Chuah; Adrian K West
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

7.  Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice.

Authors:  M Penkowa; T Moos; J Carrasco; H Hadberg; A Molinero; H Bluethmann; J Hidalgo
Journal:  Glia       Date:  1999-02-15       Impact factor: 7.452

8.  Role of metallothionein-III following central nervous system damage.

Authors:  Javier Carrasco; Milena Penkowa; Mercedes Giralt; Jordi Camats; Amalia Molinero; Iain L Campbell; Richard D Palmiter; Juan Hidalgo
Journal:  Neurobiol Dis       Date:  2003-06       Impact factor: 5.996

9.  Temporalspatial patterns of expression of metallothionein-I and -III and other stress related genes in rat brain after kainic acid-induced seizures.

Authors:  T Dalton; T L Pazdernik; J Wagner; F Samson; G K Andrews
Journal:  Neurochem Int       Date:  1995-07       Impact factor: 3.921

10.  Distribution of metallothionein in the human central nervous system.

Authors:  H G Blaauwgeers; P A Sillevis Smitt; J M De Jong; D Troost
Journal:  Glia       Date:  1993-05       Impact factor: 7.452

View more
  4 in total

Review 1.  Oxidized phospholipid signaling in traumatic brain injury.

Authors:  Tamil S Anthonymuthu; Elizabeth M Kenny; Andrew M Lamade; Valerian E Kagan; Hülya Bayır
Journal:  Free Radic Biol Med       Date:  2018-06-30       Impact factor: 7.376

2.  Increased metallothionein I/II expression in patients with temporal lobe epilepsy.

Authors:  José Eduardo Peixoto-Santos; Orfa Yineth Galvis-Alonso; Tonicarlo Rodrigues Velasco; Ludmyla Kandratavicius; João Alberto Assirati; Carlos Gilberto Carlotti; Renata Caldo Scandiuzzi; Luciano Neder Serafini; João Pereira Leite
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 3.  Metallothionein in Brain Disorders.

Authors:  Daniel Juárez-Rebollar; Camilo Rios; Concepción Nava-Ruíz; Marisela Méndez-Armenta
Journal:  Oxid Med Cell Longev       Date:  2017-09-20       Impact factor: 6.543

Review 4.  Zinc in Cognitive Impairment and Aging.

Authors:  Ruize Sun; Jue Wang; Juan Feng; Bin Cao
Journal:  Biomolecules       Date:  2022-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.